Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Grogan Donna Roy. Director active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 13 disclosures have been logged. Activity tracked since 3 October 2022. The latest transaction was filed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Grogan Donna Roy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
5,370 shares@ US$2.708.6% of flowCommon StockSEC:0001470831-26-000345:0
9,609 shares@ US$1.51Common StockSEC:0001662579-25-000052:0
9,581 shares@ US$1.4359.6% of flowCommon StockSEC:0001662579-25-000025:0
3,757 shares@ US$3.6610.0% of flowCommon StockSEC:0001662579-25-000004:0
2,474 shares@ US$5.569.4% of flowCommon StockSEC:0001662579-24-000090:0
2,836 shares@ US$4.859.7% of flowCommon StockSEC:0001662579-24-000064:0
1,697 shares@ US$8.109.7% of flowCommon StockSEC:0001662579-24-000036:0
2,108 shares@ US$6.529.4% of flowCommon StockSEC:0001662579-24-000004:0
8,089 shares@ US$1.709.9% of flowCommon StockSEC:0001662579-23-000107:0
4,858 shares@ US$2.839.5% of flowCommon StockSEC:0001662579-23-000066:0
4,298 shares@ US$3.209.5% of flowCommon StockSEC:0001662579-23-000044:0
1,763 shares@ US$6.387.9% of flowCommon StockSEC:0001662579-23-000005:0
819 shares@ US$8.695.5% of flowCommon StockSEC:0001662579-22-000006:0
About Grogan Donna Roy
GROGAN DONNA ROY is a Director of C4 Therapeutics, Inc. (XNAS). She has 11 filings in total, and across the 11 sampled filings the period runs from 2022-10-04 to 2025-04-03, with transactions of the Attribution type and buy and sell amounts of 0.